XVIR
USPTO Trademark Record · Serial No. 78555670
Trademark details
XVIR is a trademark. Serial number of that application is 78555670.
It was initially claimed by XVir Therapeutics GmbH on 20050128.
That brand applies to the following goods and services:Chemical products for research use and for use in the manufacture of pharmaceuticals, namely nucleic acids, vectors, plasmids, viruses, peptides and proteins, lipids, lipid coated proteins, lipid coated nucleic acids, lipid coated viruses, lipid coated vectors, lipid coated plasmids, antibodies, anticalines, aptamers, aptamers consisting essentially of L-nucleotides, short limiting RNA molecules without specific limitation to the number of nucleotides, antisense oligonucleotides, ribozymes, deco, Chemical products for medical and veterinary clinical use, namely nucleic acids, vectors, plasmids, viruses, peptides and proteins, lipids, lipid coated proteins, lipid coated nucleic acids, lipid coated viruses, lipid coated vectors, lipid coated plasmids, antibodies, anticalines, aptamers, spiegelmers, siRNA molecules, antisense oligonucleotides, ribosomes, decoy oligonucleotides; Pharmaceutical and veterinary preparations, namely slimming agents, appetite suppressants, acidosis therapeutics,, Scientific laboratory equipment, namely, photometers, mass spectrometers, ELISA readers, positron emission tomography (PET) scanners, thermocyclers, nuclear magnetic resonance (NMR) spectrometers, fluorescence-activated cell sorters, cell counters, and blotting devices using electric, magnetic, or capillary forces for material transfer, Scientific and medical research services in biology, molecular biology, chemistry, biochemistry, genetics, molecular genetics, and pathology; scientific and medical research services for third parties, namely, determination of viral particles, determination and sequencing of viral genome, determination of nuclear YB-1 binding protein, determination of drug resistance in samples, determination of radiation resistance in samples, design of viral vectors, design of plasmid vectors, design of viruse, Medical services featuring physicians and surgeons; veterinary services; medical services, namely, determination of individual disease risk, determination of individual cancer therapy, identifying patient groups treatable by oncolytic viruses, individual health care and managed health care services.
Currently that trademark is represented by trademark attorney(s): Matthew J. Smith.
You can learn more about that trademark on the USPTO website: View the USPTO record
It was initially claimed by XVir Therapeutics GmbH on 20050128.
That brand applies to the following goods and services:Chemical products for research use and for use in the manufacture of pharmaceuticals, namely nucleic acids, vectors, plasmids, viruses, peptides and proteins, lipids, lipid coated proteins, lipid coated nucleic acids, lipid coated viruses, lipid coated vectors, lipid coated plasmids, antibodies, anticalines, aptamers, aptamers consisting essentially of L-nucleotides, short limiting RNA molecules without specific limitation to the number of nucleotides, antisense oligonucleotides, ribozymes, deco, Chemical products for medical and veterinary clinical use, namely nucleic acids, vectors, plasmids, viruses, peptides and proteins, lipids, lipid coated proteins, lipid coated nucleic acids, lipid coated viruses, lipid coated vectors, lipid coated plasmids, antibodies, anticalines, aptamers, spiegelmers, siRNA molecules, antisense oligonucleotides, ribosomes, decoy oligonucleotides; Pharmaceutical and veterinary preparations, namely slimming agents, appetite suppressants, acidosis therapeutics,, Scientific laboratory equipment, namely, photometers, mass spectrometers, ELISA readers, positron emission tomography (PET) scanners, thermocyclers, nuclear magnetic resonance (NMR) spectrometers, fluorescence-activated cell sorters, cell counters, and blotting devices using electric, magnetic, or capillary forces for material transfer, Scientific and medical research services in biology, molecular biology, chemistry, biochemistry, genetics, molecular genetics, and pathology; scientific and medical research services for third parties, namely, determination of viral particles, determination and sequencing of viral genome, determination of nuclear YB-1 binding protein, determination of drug resistance in samples, determination of radiation resistance in samples, design of viral vectors, design of plasmid vectors, design of viruse, Medical services featuring physicians and surgeons; veterinary services; medical services, namely, determination of individual disease risk, determination of individual cancer therapy, identifying patient groups treatable by oncolytic viruses, individual health care and managed health care services.
Currently that trademark is represented by trademark attorney(s): Matthew J. Smith.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the XVIR trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate